Leveraging AI technology in sarcoidosis.

Journal: Current opinion in pulmonary medicine
PMID: 38989774

Abstract

PURPOSE OF REVIEW: Sarcoidosis is a systemic, granulomatous disease of uncertain cause. Diagnosis may be difficult, prognosis uncertain and response to treatment unpredictable. The application of artificial intelligence to sarcoidosis may provide clinical decision support for these challenges. This review will provide an overview of current and potential future applications of artificial intelligence in sarcoidosis.

Authors

  • Akiff Premjee
    Department of Medicine.
  • Lawrence Li
    Department of Medicine.
  • Srilakashmi Garikapati
    Department of Medicine.
  • Kwabena Nketiah Sarpong
    Division of Pulmonary Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Adam S Morgenthau
    Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

Keywords

External Resources

Popular Topics
Recent Journals